Clinerion Ltd Contact Details:
Main address: Margarethenstrasse 47 4053 Basel, Switzerland ,
Tel:+41 61 865 60 60 , E-mail: info(at) Website:

Clinerion Patient Network Explorer

Clinerion Patient Network Explorer

Optimized study design, precise site selection and faster patient search and identification for clinical research - in real time.

Clinerion Cookie Policy

Welcome to the Clinerion website. This website uses cookies. These cookies are used on your browser to understand how you are using our website. Using this website means you agree to our use of cookies. If you prefer not to have these cookies on your device, we advise you to disable them in your web browser settings. You accept the use of cookies by accepting this notice. You can read more details via our Privacy Policy page.

Privacy Policy page >

Webinar Recording: The scope and utility of EHR data as a source of Real World Data for Real World Evidence generation

Date: Tuesday, November 9, 2021
Time: 4 pm CET

Digital technology is enabling not only more digital engagement but also results in more digital healthcare data being generated than ever before. As a result, digital patient records are now a major source for the collection of real-world data (RWD). When used effectively, RWD can be turned into real-world evidence (RWE) and be transformative in generating evidence that supports drug efficacy and commercial healthcare application. However, the real-world data collected needs to be appropriate for use, fit for purpose, and effective in addressing the question or research topic.

In this webinar, the panel discussed their experience in working with RWD extracted from electronic health record (EHR) systems and how this compares to data that tends to be generated in randomized clinical trials (RCTs) which, today, are still the gold standard in clinical evidence generation. They touched on some of the key differences between RCT endpoints and the healthcare data recorded in the clinic that tends to drive clinical decision making, and how this affects our ability to compare RCT results with RWD for RWE generation. And they explored some of the growing benefits and opportunities that EHR data presents in making clinical research more effective and efficient.

We heard the following topics from the following experts:


  • From insight to evidence: building regulatory and scientific grade data sources for Europe – Romain Finas, VP Real-World Evidence, Alira Health
  • Using Anonymized EMR data to develop RWD real time cohort models – Douglas Drake, Senior Director, Customer Solutions, Clinerion
  • Real World Data Analytics in Clinical Research – Ahmed El Rhali, President & CEO, Datametrix
  • Panel Discussion – Douglas Drake, Ahmed El Rhali, Romain Finas

Please fill in the form below to access the recording.


Romain Finas
VP Real-World Evidence
Alira Health

Romain Finas has been building the Real-World Evidence practice for Alira Health since mid-2020. Prior to Alira Health, Romain designed and implemented the “beyond the pill” strategy for MSD France. Among other initiatives, he started living labs to test and assess innovations based on real-time data routinely collected by practitioners. Romain has 20 years of experience in consultancy, healthcare and digital.

Douglas Drake
Senior Director, Customer Solutions

Douglas Drake, MS, MBA, is originally a life science researcher with a passion for digital enablement of better patient care. For over 30 years, Douglas has worked in various aspects of diagnostics, therapeutic research, drug discovery and global business development. He has broad experience in transformative technologies, data sciences, digital healthcare and applying these to improving patient engagement and the patient journey.

Ahmed El Rhali 
President & CEO

Ahmed El Rhali is an expert in Data Science, Clinical Trials and Biotechnology. Since 2015 he is President and CEO of datametrix AG, supporting companies in generating the information they need, for making better and faster decisions driving business and clinical benefits and results.

With extensive knowledge and experience in those fields thanks to the numerous years he spent working in senior positions (MD, VP) for large pharma organizations and CRO’s, Ahmed knows your challenges as a decision maker and knows the importance of data to help taking the best, most informed decisions, accelerate timelines and save money to a business unit and even to your organization as a whole.

Please fill in the form below to access the recording.

Register today:


Personal Data Protection Statement

The information you provide allows us to provide you with information and updates on Clinerion’s products and services (the purpose). By submitting your details in the registration form, you give explicit consent that your personal details may be used for this and only this purpose by Clinerion and webinar partners, who may also provide you with information and updates on their products and services.

Clinerion, as the data controller and processor, will maintain the data for as long as the data is required for the purposes mentioned above, or until you withdraw consent as stated below. Personal data are not kept longer than necessary and are processed in a manner that ensures appropriate security and confidentiality, including for preventing unauthorized access to or use of personal data and the equipment used for the processing.

We will not sell or give away any personal information that you provide and only use it for the purposes stated above. You may request to view, correct, or delete your data in Clinerion’s database or withdraw consent by contacting Please note that withdrawal of consent shall not affect the lawfulness of Clinerion’s use of your personal data for the purposes mentioned above before withdrawal of consent.

The legal address of Clinerion: Clinerion Ltd, Elisabethenanlage 11, 4051 Basel, Switzerland. e-Mail address